Literature DB >> 1730682

Transforming and c-fos promoter/enhancer-stimulating activities of a stimulatory GDP/GTP exchange protein for small GTP-binding proteins.

H Fujioka1, K Kaibuchi, K Kishi, T Yamamoto, M Kawamura, T Sakoda, T Mizuno, Y Takai.   

Abstract

smg GDP dissociation stimulator (GDS) is a stimulatory GDP/GTP exchange protein for a group of ras p21-like small GTP-binding proteins (G proteins) including c-Ki-ras p21, smg p21A, smg p21B, and rhoA p21. smg GDS converts the GDP-bound inactive form to the GTP-bound active form of each small G protein by stimulating their GDP/GTP exchange reaction in a cell-free system. The point-mutated c-Ki-ras p21 (c-Ki-rasval12 p21) is known to strongly transform NIH/3T3 cells and to markedly stimulate the c-fos promoter/enhancer in this cell line, whereas the normal c-Ki-ras p21 is weak in these activities. In the present study, we examined the effect of smg GDS on these activities to explore its physiological function. Overexpression of both smg GDS and c-Ki-ras p21 strongly transformed NIH/3T3 cells, whereas overexpression of either smg GDS or c-Ki-ras p21 alone weakly transformed the cells. Furthermore, overexpression of both smg GDS and c-Ki-ras p21 markedly stimulated the c-fos promoter/enhancer in NIH/3T3 cells, whereas overexpression of either smg GDS or c-Ki-ras p21 alone weakly stimulated it. These results indicate that smg GDS transforms NIH/3T3 cells and stimulates the c-fos promoter/enhancer in this cell line in cooperation with c-Ki-ras p21.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730682

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Involvement of a small GTP-binding protein (G protein) regulator, small G protein GDP dissociation stimulator, in antiapoptotic cell survival signaling.

Authors:  A Takakura; J Miyoshi; H Ishizaki; M Tanaka; A Togawa; Y Nishizawa; H Yoshida; S i Nishikawa; Y Takai
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

2.  Identification of residues critical for Ras(17N) growth-inhibitory phenotype and for Ras interaction with guanine nucleotide exchange factors.

Authors:  L A Quilliam; K Kato; K M Rabun; M M Hisaka; S Y Huff; S Campbell-Burk; C J Der
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

Review 3.  The Ras signal transduction pathway.

Authors:  R Khosravi-Far; C J Der
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

4.  SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers.

Authors:  Nathan J Schuld; Andrew D Hauser; Adam J Gastonguay; Jessica M Wilson; Ellen L Lorimer; Carol L Williams
Journal:  Cell Cycle       Date:  2014-01-16       Impact factor: 4.534

5.  Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes.

Authors:  Y Yoshida; M Kawata; Y Miura; T Musha; T Sasaki; A Kikuchi; Y Takai
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

6.  A novel role for RhoGDI as an inhibitor of GAP proteins.

Authors:  J F Hancock; A Hall
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

7.  Mutated RAP1GDS1 causes a new syndrome of dysmorphic feature, intellectual disability & speech delay.

Authors:  Abdulaziz Asiri; Essra Aloyouni; Muhammad Umair; Yusra Alyafee; Abeer Al Tuwaijri; Kheloud M Alhamoudi; Bader Almuzzaini; Abeer Al Baz; Deemah Alwadaani; Marwan Nashabat; Majid Alfadhel
Journal:  Ann Clin Transl Neurol       Date:  2020-05-19       Impact factor: 4.511

Review 8.  SmgGDS: An Emerging Master Regulator of Prenylation and Trafficking by Small GTPases in the Ras and Rho Families.

Authors:  Anthony C Brandt; Olivia J Koehn; Carol L Williams
Journal:  Front Mol Biosci       Date:  2021-06-16

9.  SmgGDS antagonizes BPGAP1-induced Ras/ERK activation and neuritogenesis in PC12 cell differentiation.

Authors:  Aarthi Ravichandran; Boon Chuan Low
Journal:  Mol Biol Cell       Date:  2012-11-14       Impact factor: 4.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.